Thermo Fisher Scientific (TMO) Tops Q3 EPS by $1.09
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Thermo Fisher Scientific (TMO) PT Raised to $715 at Cowen
October 28, 2021 8:07 AM EDTCowen analyst Dan Brennan raised the price target on Thermo Fisher Scientific (NYSE: TMO) to $715.00 (from $696.00) while maintaining an Outperform rating.
The analyst commented, "TMO reported a good 3Q, with COVID testing a big driver along with healthy organic growth ex-COVID of 10%... More
Thermo Fisher set to benefit from demand for testing kits, vaccines
October 26, 2021 1:22 PM EDTBy Amruta Khandekar and Mrinalika Roy
(Reuters) - Thermo Fisher Scientific Inc's third-quarter profit is likely to get a boost from a rebound in COVID-19 testing due to the highly contagious Delta variant and sustained demand for vaccines against the coronavirus, Wall Street analysts said.
In July, when cases eased in the United States, the company cut its annual sales forecast for COVID-19 tests by $900 million. But the demand has again picked up pace in recent months amid a surge in Delta-led infections.
The world's largest maker of scientific instruments, which also supplies raw materials for COVID-19... More
